Summary
Levels of 5-hydroxyindoleacetic acid and homovanillic acid were measured in cerebrospinal fluid from 33 depressed women with no clinical response to amitriptyline, before and after combination treatment with triiodothyronine. Although the latter showed significant clinical improvement, changes in CSF amine metabolites did not differ significantly from a control group of 16 therapy-resistant depressed women receiving higher doses of amitriptyline. Possible explanations for the mechanism of action of triiodothyronine are discussed.
Similar content being viewed by others
Abbreviations
- 5-HIAA:
-
5-hydroxyindoleacetic acid
- HVA:
-
homovanillic acid
- CSF:
-
cerebrospinal fluid
- T3 :
-
triiodothyronine
References
Abdullah, Y. H., Hamadah, K.: 3′5′-cyclic adenosine monophosphate in depression and mania. Lancet1970 I, 378–381
Akiskal, H. S., McKinney, W. T.: Overview of recent research in depression. Arch. gen. Psychiat.32, 285–305 (1975)
Ashcroft, G., Crawford, T., Eccleston, E., Sharman, D. F., McDougall, E. J., Stanton, J. B., Binns, K.: 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet1966 II, 1049–1052
Banki, C. M.: Triiodothyronine in the treatment of depression. Orv. Hetil.116, 2543–2547 (1975)
Banki, C. M.: Cerebrospinal fluid 5-hydroxyindoleacetic acid in mania and depression. Ideggyóg. Szle29, 467–479 (1976)
Banki, C. M.: Cerebrospinal fluid homovanillic acid concentrations in manic and depressed patients. Ideggyóg. Szle (in press)
Breulet, M., Bourdouxhe, S., Parent, M., Legros, J. J., Bobon, J.: Clinical and neuroendocrinological study of the TRH in melancholia. Acta psychiat. Belg.74, 254–277 (1974)
Brodie, B. B., Davis, J. I., Heynie, S.: Interrelationships of catecholamines with other endocrine systems. Pharmacol. Rev.18, 273–281 (1966)
Cavalca, G. G., Covezzi, E., Boncinelli, A.: Clinical experiences with the combination of thyroid extract and tricyclics in the treatment of depressed patients. Riv. sper. Freniat.98, 271–300 (1974)
Coppen, A., Prange, A. J., Whybrow, P. C., Noguera, R.: Abnormalities of indoleamines in affective disorders. Arch. gen. Psychiat.26, 474–478 (1972)
Dencker, S., Malm, U., Roos, B. E.: Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem.13, 1545–1548 (1966)
Earle, B. V.: Thyroid hormone and tricyclic antidepressants in resistant depressions. Amer. J. Psychiat.126, 1667–1669 (1970)
Fuxe, K., Ungerstedt, U.: Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-HT. Europ. J. Pharmacol.4, 135–144 (1968)
Gerbode, F. A., Bowers, M. B.: Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid. J. Neurochem.15, 1053–1055 (1968)
Glowinski, J., Axelrod, J.: Inhibition of uptake of tritiated noradrenaline in the intact brain by imipramine and structurally related compounds. Nature204, 1318–1319 (1964)
Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat.23, 56–62 (1960)
Korf, J., Valkenburgh-Sikkema, T.: Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid. Clin. chim. Acta26, 301–306 (1969)
Mathematik und Statistik. Basel: Documenta Geigy 1975
Mendels, J., Frazer, A., Fitzgerald, R. G., Ramsey, T. A., Stokes, J. W.: Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients. Science175, 1380–1382 (1972)
Ogura, C., Okuma, T., Uchida, Y., Kato, N.: Combined triiodothyroninetricyclic antidepressant treatment in depressive states. Folia psychiat. neurol. jap.28, 179–186 (1974)
Papeschi, R., McClure, D. J.: Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. gen. Psychiat.25, 354–358 (1971)
Paul, M. I., Ditzion, B. R., Pauk, G. L., Janowsky, D. S.: Urinary adenosine-3′5′-monophosphate excretion in affective disorders. Amer. J. Psychiat.126, 1493–1497 (1970)
Prange, A. J., Wilson, I. C., Rabon, A. M., Lipton, M. A.: Enhancement of imipramine by triiodothyronine in nonselected depressed patients. Excerpta med. Int. Congress Series180, 532–535 (1968)
Prange, A. J., Wilson, I. C., Rabon, A. M., Lipton, M. A.: Enhancement of imipramine antidepressant activity by thyroid hormone. Amer. J. Psychiat.126, 457–469 (1969)
Prange, A. J., Wilson, I. C., Knox, A., McClane, T. K., Lipton, M. A.: Enhancement of imipramine by thyroid stimulating hormone: clinical and theoretical implications. Amer. J. Psychiat.127, 191–199 (1970)
Ramsden, E. N.: Cyclic AMP in depression and mania. Lancet1970 II, 108–110
Sabelli, H. C., Mosnaim, A. D., Vazquez, A. J.: Phenylethylamine, possible role in depression and antidepressive drug action. In: Neurohumoral coding of brain function, (eds. R. D. Myers, R. R. Drucker-Colin) pp. 331–357. New York: Plenum Publ. Co. 1975
Schildkraut, J. J., Winokur, A., Applegate, C. W.: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science168, 867–869 (1970)
Sinanan, K., Keatinge, A. M., Beckett, P. G., Clayton-Love, W.: Urinary cyclic AMP in endogenous and neurotic depression. Brit. J. Psychiat.126, 49–55 (1975)
Sjöström, R., Roos, B. E.: 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of manic-depressive psychoses. Europ. J. clin. Pharmacol.4, 170–176 (1972)
Van Praag, H. M., Korf, J.: Retarded depression and dopamine metabolism. Psychopharmacologia (Berl.)19, 199–203 (1971)
Van Praag, H. M, Korf, J., Schut, J.: Cerebral monoamines and depression; investigation with the probenecid technique. Arch. gen. Psychiat.28, 827–832 (1973)
Wilson, I. C., Prange, A. J., McClane, T. K., Rabon, A. M., Lipton, M. A.: Thyroid hormone enhancement of imipramine in non-retarded depressions. New Engl. J. Med.282, 1063–1067 (1970)
Wheatley, D.: Potentiation of amitriptyline by thyroid hormone. Arch. gen. Psychiat.26, 229–233 (1972)
Whybrow, P. C., Prange, A. J., Treadway, D. R.: Mental changes accompanying thyroid gland dysfunction. Arch. gen. Psychiat.20, 48–63 (1969)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banki, C.M. Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women. Eur J Clin Pharmacol 11, 311–315 (1977). https://doi.org/10.1007/BF00607682
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607682